Literature DB >> 17255566

Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?

Kevin R Flaherty1, Adin-Cristian Andrei, Talmadge E King, Ganesh Raghu, Thomas V Colby, Athol Wells, Nadir Bassily, Kevin Brown, Roland du Bois, Andrew Flint, Steven E Gay, Barry H Gross, Ella A Kazerooni, Robert Knapp, Edmund Louvar, David Lynch, Andrew G Nicholson, John Quick, Victor J Thannickal, William D Travis, James Vyskocil, Frazer A Wadenstorer, Jeffrey Wilt, Galen B Toews, Susan Murray, Fernando J Martinez.   

Abstract

RATIONALE: Treatment and prognoses of diffuse parenchymal lung diseases (DPLDs) varies by diagnosis. Obtaining a uniform diagnosis among observers is difficult.
OBJECTIVES: Evaluate diagnostic agreement between academic and community-based physicians for patients with DPLDs, and determine if an interactive approach between clinicians, radiologists, and pathologists improved diagnostic agreement in community and academic centers.
METHODS: Retrospective review of 39 patients with DPLD. A total of 19 participants reviewed cases at 2 community locations and 1 academic location. Information from the history, physical examination, pulmonary function testing, high-resolution computed tomography, and surgical lung biopsy was collected. Data were presented in the same sequential fashion to three groups of physicians on separate days.
MEASUREMENTS AND MAIN RESULTS: Each observer's diagnosis was coded into one of eight categories. A kappa statistic allowing for multiple raters was used to assess agreement in diagnosis. Interactions between clinicians, radiologists, and pathologists improved interobserver agreement at both community and academic sites; however, final agreement was better within academic centers (kappa = 0.55-0.71) than within community centers (kappa = 0.32-0.44). Clinically significant disagreement was present between academic and community-based physicians (kappa = 0.11-0.56). Community physicians were more likely to assign a final diagnosis of idiopathic pulmonary fibrosis compared with academic physicians.
CONCLUSIONS: Significant disagreement exists in the diagnosis of DPLD between physicians based in communities compared with those in academic centers. Wherever possible, patients should be referred to centers with expertise in diffuse parenchymal lung disorders to help clarify the diagnosis and provide suggestions regarding treatment options.

Entities:  

Mesh:

Year:  2007        PMID: 17255566      PMCID: PMC1899268          DOI: 10.1164/rccm.200606-833OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  22 in total

Review 1.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

2.  Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis.

Authors:  G W Hunninghake; M B Zimmerman; D A Schwartz; T E King; J Lynch; R Hegele; J Waldron; T Colby; N Müller; D Lynch; J Galvin; B Gross; J Hogg; G Toews; R Helmers; J A Cooper; R Baughman; C Strange; M Millard
Journal:  Am J Respir Crit Care Med       Date:  2001-07-15       Impact factor: 21.405

3.  Estimating equations for kappa statistics.

Authors:  J R Thompson
Journal:  Stat Med       Date:  2001-10-15       Impact factor: 2.373

4.  Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia.

Authors:  Gary W Hunninghake; David A Lynch; Jeffrey R Galvin; Barry H Gross; Nestor Müller; David A Schwartz; Talmadge E King; Joseph P Lynch; Richard Hegele; James Waldron; Thomas V Colby; James C Hogg
Journal:  Chest       Date:  2003-10       Impact factor: 9.410

5.  Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia.

Authors:  W D Travis; K Matsui; J Moss; V J Ferrans
Journal:  Am J Surg Pathol       Date:  2000-01       Impact factor: 6.394

6.  Histopathologic variability in usual and nonspecific interstitial pneumonias.

Authors:  K R Flaherty; W D Travis; T V Colby; G B Toews; E A Kazerooni; B H Gross; A Jain; R L Strawderman; A Flint; J P Lynch; F J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2001-11-01       Impact factor: 21.405

7.  The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.

Authors:  G Raghu; Y N Mageto; D Lockhart; R A Schmidt; D E Wood; J D Godwin
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

8.  The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

Authors:  A G Nicholson; T V Colby; R M du Bois; D M Hansell; A U Wells
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

9.  Clinical significance of histological classification of idiopathic interstitial pneumonia.

Authors:  K R Flaherty; G B Toews; W D Travis; T V Colby; E A Kazerooni; B H Gross; A Jain; R L Strawderman; R Paine; A Flint; J P Lynch; F J Martinez
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

10.  Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia.

Authors:  Kevin R Flaherty; Jeanette A Mumford; Susan Murray; Ella A Kazerooni; Barry H Gross; Thomas V Colby; William D Travis; Andrew Flint; Galen B Toews; Joseph P Lynch; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2003-05-28       Impact factor: 21.405

View more
  50 in total

1.  Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.

Authors:  MeiLan K Han; Yueren Zhou; Susan Murray; Nabihah Tayob; Imre Noth; Vibha N Lama; Bethany B Moore; Eric S White; Kevin R Flaherty; Gary B Huffnagle; Fernando J Martinez
Journal:  Lancet Respir Med       Date:  2014-04-21       Impact factor: 30.700

2.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

3.  Diffuse interstitial lung disease: overlaps and uncertainties.

Authors:  Simon L F Walsh; David M Hansell
Journal:  Eur Radiol       Date:  2010-03-04       Impact factor: 5.315

4.  Volume-related structures predict UIP pathology in those with a non-IPF pattern on CT.

Authors:  Jonathan H Chung; Ayodeji Adegunsoye; Justin M Oldham; Rekha Vij; Aliya Husain; Steven M Montner; Ronald A Karwoski; Brian J Bartholmai; Mary E Strek
Journal:  Eur Radiol       Date:  2021-04-13       Impact factor: 5.315

5.  A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

Authors:  Christopher J Ryerson; Tamera J Corte; Joyce S Lee; Luca Richeldi; Simon L F Walsh; Jeffrey L Myers; Jürgen Behr; Vincent Cottin; Sonye K Danoff; Kevin R Flaherty; David J Lederer; David A Lynch; Fernando J Martinez; Ganesh Raghu; William D Travis; Zarir Udwadia; Athol U Wells; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

Review 6.  Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.

Authors:  Margaret L Salisbury; Jeffrey L Myers; Elizabeth A Belloli; Ella A Kazerooni; Fernando J Martinez; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

7.  ENERGY SENSING PATHWAYS IN AGING AND CHRONIC LUNG DISEASE.

Authors:  Victor J Thannickal
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

8.  Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

Authors:  Simon L F Walsh; Toby M Maher; Martin Kolb; Venerino Poletti; Richard Nusser; Luca Richeldi; Carlo Vancheri; Margaret L Wilsher; Katerina M Antoniou; Jüergen Behr; Elisabeth Bendstrup; Kevin Brown; Lucio Calandriello; Tamera J Corte; Vincent Cottin; Bruno Crestani; Kevin Flaherty; Ian Glaspole; Jan Grutters; Yoshikazu Inoue; Maria Kokosi; Yasuhiro Kondoh; Vasileios Kouranos; Michael Kreuter; Kerri Johannson; Eoin Judge; Brett Ley; George Margaritopoulos; Fernando J Martinez; Maria Molina-Molina; António Morais; Hilario Nunes; Ganesh Raghu; Christopher J Ryerson; Moises Selman; Paolo Spagnolo; Hiroyuki Taniguchi; Sara Tomassetti; Dominique Valeyre; Marlies Wijsenbeek; Wim Wuyts; David Hansell; Athol Wells
Journal:  Eur Respir J       Date:  2017-08-31       Impact factor: 16.671

9.  Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.

Authors:  Margaret L Salisbury; Meng Xia; Susan Murray; Brian J Bartholmai; Ella A Kazerooni; Catherine A Meldrum; Fernando J Martinez; Kevin R Flaherty
Journal:  Respir Med       Date:  2016-07-28       Impact factor: 3.415

10.  Quantitative computed tomography imaging of interstitial lung diseases.

Authors:  Brian J Bartholmai; Sushravya Raghunath; Ronald A Karwoski; Teng Moua; Srinivasan Rajagopalan; Fabien Maldonado; Paul A Decker; Richard A Robb
Journal:  J Thorac Imaging       Date:  2013-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.